I suggest going with the first option, which is to do the clinical research in Albania. The first approach is the most cost-efficient and successful way to ensure that the drug quickly hits the market and helps those who have frequent panic attacks. Additionally, it guarantees profits while encouraging exposure to and development of investments. However, I also support the third option, which calls for transferring a portion of the trial-related funds to Albania in return for their support, volunteers, and help.

Do you agree r disagree? Why?